Barclays Maintains an 'Equalweight' on Texas Instruments (TXN); Beginning of Broad-Based Recovery
Tweet
Share
E-mailGet Alerts TXN Hot Sheet
Price: $279.58 +2.25%
Rating Summary:
24 Buy, 22 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
24 Buy, 22 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Texas Instruments (NASDAQ: TXN) price target of $35.00.
Analyst, C.J. Muse, said, "TI reported a clean beat and raise, suggesting consensus estimates are moving higher, led by a trough in inventory depletion, particularly in auto, industrial, and comm infrastructure...We still see upside to $35, but more meaningful upside would require a bigger up-cycle to lift GMs."
Muse said that TI's management was hesitant to make suggestions regarding the recovery, but did guide to the high-end. Muse raises FY12 EPS from $1.80 to $1.85 and revs from $13.7 bln to $13.9 bln. For FY13, EPS maintained at $2.30)
For an analyst ratings summary and ratings history on Texas Instruments click here. For more ratings news on Texas Instruments click here.
Shares of Texas Instruments closed at $31.89 yesterday.
Analyst, C.J. Muse, said, "TI reported a clean beat and raise, suggesting consensus estimates are moving higher, led by a trough in inventory depletion, particularly in auto, industrial, and comm infrastructure...We still see upside to $35, but more meaningful upside would require a bigger up-cycle to lift GMs."
Muse said that TI's management was hesitant to make suggestions regarding the recovery, but did guide to the high-end. Muse raises FY12 EPS from $1.80 to $1.85 and revs from $13.7 bln to $13.9 bln. For FY13, EPS maintained at $2.30)
For an analyst ratings summary and ratings history on Texas Instruments click here. For more ratings news on Texas Instruments click here.
Shares of Texas Instruments closed at $31.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
